Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2021 | Sequential CD19 and BCMA CAR-T

Chengcheng Fu, MD, PhD, The First Affiliated Hospital of Soochow University, Suzhou, China, discusses investigations of sequential CAR-T infusion, whereby CD19 CAR-T is given and followed up by infusion of a B-cell maturation antigen (BCMA)-targeting CAR. Chengcheng Fu goes on to highlight the high expense of this kind of therapy and the potential of frontline CAR-T. This interview took place during the 2nd Immune Effector Cell Therapy in MM Workshop in Boston, MA.